Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.50
Bid: 8.40
Ask: 8.60
Change: 0.10 (1.19%)
Spread: 0.20 (2.381%)
Open: 8.40
High: 8.50
Low: 8.25
Prev. Close: 8.40
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Seed Investment in Bond Pets LLC

5 Sep 2019 07:00

RNS Number : 2626L
Agronomics Limited
05 September 2019
 

5 September 2019

 

Agronomics Limited 

("Agronomics" or the "Company")

 

Seed Investment in Bond Pets LLC

 

The Board of AIM-quoted Agronomics, trading under the symbol ANIC, is pleased to announce that the Company has today subscribed for US $150,000 of convertible promissory notes (the "Subscription") in Bond Pets LLC's ("Bond"). The Subscription, funded from existing cash resources, is in line with the Company's investing strategy by participating in clean meat opportunities globally and, under the terms of the Subscription, will give the Company an approximate 3% to 4% equity interest in the Company, dependent on the valuation of Bond upon conversion.

 

Bond was co-founded by Rich Kelleman, CEO and Pernilla Audibert, CTO in 2018. Bond is a leader in the animal-free pet food sector and is, as far as the Company is aware, currently the only operation in the world producing chicken protein using fermentation techniques for incorporation into pet food products. Bond anticipates the launch of its first protein-rich dog treats in the US in Q1 2020 under the Bond Pet Foods brand.

 

Bond is an early stage, pre-revenue company with a cash burn rate of US $8,500 per month and net assets of approximately US$ 113,700 as at 31st July 2019.

 

Zion Research expect the US pet food market to reach US $30.01 billion in sales in 2022, with dog food accounting for approximately 70% of the market. Chicken is a popular flavour globally, found predominantly in both dog and cat food. The investment supports concerns of animal welfare within the pet food industry and the wider growing concerns of meat consumption in relation to climate change.

 

Richard Reed, Chairman of Agronomics, commented: -

 

"Bond Pet Foods represents an opportunity to expand our mission and remove animals from the pet food supply chain reduce the strain on the scarce resources of land, water and energy. With a simpler regulatory path for pet food, Bond has the opportunity to generate revenues"

 

Rich Kelleman, founder and CEO of Bond, added: -

 

"We're thrilled with Agronomics' commitment to our venture and are excited to have them on our team. Together we will deliver high quality protein and nutrition to dogs and cats - some of the world's biggest consumers of meat products - and help mitigate many of the negative impacts inherent with meat production."

 

Terms of the Convertible Promissory Note

 

Total Raise: US$ 1 million, inclusive of US$ 175,000 of already-issued notes

Pre-money valuation: US$ 3.6 million

Lead Investor: Hexagon Special Opportunities SPC

Liquidation preference: 1x

Mandatory conversion: Next qualifying financing shall convert to shares of capital stock at the conversion price of 80% of the prior preferred stock or after 24 months (the maturity date)

Pre-emption rights: Yes - the right to purchase the portion of equity securities offered by the Company equal to the number of shares of Company securities held. Oversubscription right with respect to shares.

5% option pool allocated prior to the Conversion of the Notes

 

About Bond Pets

 

Bond Pets LLC is a Boulder, Colorado-based pet food company that's reinventing pet nutrition, making dog and cat foods sourced from real meat protein, without the animal. Using some of the same processes that are employed in craft brewing, Bond grows high-quality animal proteins through fermentation, harvests them to better meet the nutrition requirements of companion animals, and uses the ingredients as the foundation of its complete recipes.

 

About Agronomics Limited

 

Agronomics Limited is an investment company focused on opportunities within the nascent industry of modern foods, which are environmentally friendly alternatives to the traditional production of meat and plant-based sources of nutrition. It established an investment policy in April 2019, with a board of directors including Richard Reed, Jim Mellon, David Giampaolo, Denham Eke and Anderson Whamond. The Agronomics team are highly experienced entrepreneurs, investors and advisors with a track record of success.

Agronomics believes that the recent developments within cellular agriculture and alternative protein space will provide valuable contributions to meet the demands of increased global population growth and meat consumption in the future. The company sees cellular agriculture and aquaculture (also called cell-based or "clean meat") as a viable solution to relieve the pressure on arable farming and land usage.

For further information, please contact:

Agronomics Limited

Beaumont Cornish Limited

Optiva Securities Limited

Peterhouse Capital Limited

Britton Financial PR

The Company

Nomad

Joint Broker

Joint Broker

Investor Relations

Denham Eke

+44 (0) 1624 639396

Roland Cornish/James Biddle

+44 (0) 207 628 3396

Jeremy King

+44 (0) 203 137 1904

Lucy Williams

+44 (0) 207 469 0936

 

Tim Blackstone

+44 (0)7957 140416

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLIMFTMBBMBLL
Date   Source Headline
12th Oct 20167:00 amRNSNet Asset Value(s)
22nd Jul 20167:00 amRNSNet Asset Value(s)
29th Apr 20167:00 amRNSNet Asset Value calculation to 31 March 2016
15th Apr 20167:00 amRNSChange of Adviser
18th Mar 20167:00 amRNSHolding(s) in Company
17th Mar 20167:00 amRNSInterim Results for the six months to 31 Dec 2015
10th Feb 201612:11 pmRNSResult of AGM
25th Jan 20167:00 amRNSNet Asset Value(s)
22nd Dec 20157:00 amRNSAnnual Audited Results and Notice of AGM
17th Dec 20154:00 pmRNSDBC receives US FDA approval to market PulseFlowDF
4th Nov 20157:00 amRNSNet Asset Value(s)
30th Jul 20157:01 amRNSNet Asset Value(s)
15th Apr 20157:00 amRNSNet Asset Value as at 31 March 2015
30th Mar 20157:00 amRNSInterim results for 6 months to 31 December 2014
6th Feb 201512:21 pmRNSClose of Tender Offer
4th Feb 20155:36 pmRNSRe Results of Tender Offer
2nd Feb 20158:00 amRNSResults of Tender Offer
23rd Jan 20157:00 amRNSHolding(s) in Company
15th Jan 201511:56 amRNSHolding(s) in Company
14th Jan 20157:00 amRNSTender Offer
12th Jan 20159:32 amRNSNet Asset Value
30th Dec 20147:00 amRNSAnnual audited results
23rd Dec 201411:58 amRNSHolding(s) in Company
28th Nov 20142:04 pmRNSTender Offer in respect of Magna Biopharma
21st Oct 20147:00 amRNSNet Asset Value to 30 September 2014
22nd Jul 20147:00 amRNSNet Asset Value(s)
8th Apr 20147:00 amRNSNet Asset Value calculations to 31 March 2014
31st Mar 20147:00 amRNSInterim Results for the six months to 31 Dec 2013
24th Jan 201411:21 amRNSHolding(s) in Company
20th Jan 201410:56 amRNSHolding(s) in Company
17th Jan 20147:00 amRNSNet Asset Value(s)
15th Jan 20147:00 amRNSAppointment of Nominated Adviser
6th Jan 20145:49 pmRNSHolding(s) in Company
20th Nov 20134:04 pmRNSHolding(s) in Company
13th Nov 20135:13 pmRNSHolding(s) in Company
12th Nov 20137:00 amRNSResult of General Meeting
24th Oct 20137:01 amRNSNotice of General Meeting
24th Oct 20137:00 amRNSAnnual Financial Report
18th Oct 201311:23 amRNSHolding(s) in Company
18th Oct 20137:00 amRNSNet Asset Value(s)
4th Oct 20132:13 pmRNSHolding(s) in Company
26th Sep 20135:10 pmRNSHolding(s) in Company
13th Sep 201311:32 amRNSHolding(s) in Company
6th Sep 20135:29 pmRNSHolding(s) in Company
6th Aug 20139:40 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSNet Asset Value(s)
15th Apr 201312:34 pmRNSDirectorate Change
12th Apr 20132:17 pmRNSHolding(s) in Company
10th Apr 20137:00 amRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSNet Asset Value calculation to 31st March 2013

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.